The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Could be take over target with that cash
Yes I thought perhaps there was an RNS. It's very small cap so doesn't take much. I use them for structured products - seem ok but not convinced enough to buy.
Interesting lurch into life
And they'll start to make interest on their cash now
Market cap = £12.4
Net cash position of £8.38 million
Therefore 67% of market cap held in cash!
Profitable, and paying a dividend of c2.5%.
I see 30000 sells have now gone through but shown as unknown
Sold 30000 today yet not shown
One of the directors has more than 12 mill shares, nearly 30% of total so they certainly have confidence , although 2.5% divi ok .
Revenue up 9%
AuM up 6%
Net cash £8.3m
Interim dividend doubled.
Possible takeover to one side, this seems to have turned a corner ad be making decent headway. Possible GARP?
Thinking it was Walker Crisps.
What an uncanny resemblance.
Director now has around 20% I think.
Maybe the 65p offer is near.
Apart from the director buy with subsequent rise to around 30p . I see no reason for the fall from 39p last year to 24p or the rise back to these levels. ?!?
Unless others know better.
you referring to PSL
Came out at 4.09 today, muppets. This will get hammered tomorrow. Should have waited until the morning.
I now understand it will be 02/08/18
Another year, yet again no indication as to the date when the results will be announced.
What do u mean
They will be rubbing their hands with glee soon enough when their little lightbulb shop they are financing signs the deal of the century. Enjoy the show :)
When are they going to announce the results.
1.85p dividend, 900k profit last year and near the yearly low. Looks like a bargain.
Included in Simon Thompson's 2016 Bargain Shares ten picks, should be in for an interesting day. http://www.investorschronicle.co.uk/2016/02/04/comment/simon-thompson/bargain-shares-ouDVdXEGc4kyF21csXuS0L/article.html
BUT it tends to go to sleep and fall back as its quite illiquid.
Nice.
HIGHLIGHTS Group revenues increased by 22% to £13.3m (2014: £10.9m) Gross profit (net revenues) increased by 20% to £8.9m (2014: £7.4m) Increase in FSCS Levy charged to income for the period to £402,000 (2014 restated: £310,000) being a full year's cost taken completely in the first half year under IFRIC21 Profit before taxation up five-fold to £589,000 (2014 restated: £115,000) Interim dividend increased by 9% to 0.58p per share (2014: 0.53p per share) Fee and non-broking income now 60% of total income (2014: 57%), reflecting the strategy to reduce reliance on transaction-driven commission revenue ? Total Assets under Management and Administration (AUMA) increased by 22% to £3.9 billion (30 Sep 2014: £3.2 billion; 31 Mar 2015: £3.8 billion) Discretionary and Advisory Assets under Management represent £2.1 billion (30 September 2014: £1.6 billion), an increase of 31%